#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine adenocarcinoma Immunodeficiency common variable Progressive multifocal leukoencephalopathy Mucous membrane pemphigoid Familial haemophagocytic lymphohistiocytosis B-cell small lymphocytic lymphoma Prodromal Alzheimer's disease Alveolar proteinosis Hypereosinophilic syndrome Still's disease Neurodegenerative disorder Congenital megacolon Hypocalcaemia Congenital absence of bile ducts Acute lymphocytic leukaemia recurrent More trials…

    Learn about Rare Diseases

    Proteus syndrome – Diagnostics Biotinidase deficiency Adrenogenital syndrome – Trials in Disease Medulloblastoma – Basic Information Hereditary hypophosphataemic rickets Fragile X syndrome – Trials in Disease Angiosarcoma – Treatment Myxofibrosarcoma – Basic Information Waldenstrom’s macroglobulinaemia – Diagnostics Glycogen storage disease type II – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Placebo Cldn6 Rna-Lpx Mezigdomide Protamine Sulfate ZIMISLECEL Bemnifosbuvir Hemisulfate ASP3082 Io102 Hydrochloride Rugonersen Gadoteridol Zilovertamab Vedotin Lactose Monohydrate PRILOCAINE HYDROCHLORIDE Gebasaxturev Ecoo6A Atidarsagene Autotemcel CLESROVIMAB Selinexor Betamethasone Sodium Phosphate Permethrin More therapies…

    Learn about Your Condition

    Small cell carcinoma Elderly Brain stem glioma Metastases to lymph nodes Systemic scleroderma Aplasia pure red cell Mucous membrane pemphigoid Coronary artery bypass Glomerulonephritis chronic Biotinidase deficiency Endometrial cancer stage I Chronic myeloid leukaemia Hyperinsulinism Dermatomyositis Acute on chronic liver failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

    Recruiting

    3 1
    Czechia Germany Greece Ireland Poland

  • Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • TRAZODONE HYDROCHLORIDE
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Italy

  • Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Aripiprazole
    • Fluoxetine Hydrochloride
    • Risperidone
    Bulgaria Romania

  • Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    France

  • Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • 5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
    Bulgaria Czechia France Hungary Italy Poland +3

  • A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • GXV813
    Bulgaria
1 2 3 … 42
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!